课题基金 / 基金详情

Identification of Splicing-Related Aging Biomarkers

Identification of Splicing-Related Aging Biomarkers
剪接相关衰老生物标志物的鉴定
批准号:
8929113
负责人:
KAN CAO
金额:
$17.85万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-30 至 2018-05-31

项目摘要

项目成果

KAN CAO的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):细胞衰老是一个强大的体外模型,用于探索生物衰老的分子机制。一种流行的假设是,当端粒缩短到临界点以下时,它就像一个有丝分裂钟,决定了细胞周期的永久退出。除了端粒缩短外,某些癌基因或环境刺激(如γ辐射)也可提前引发细胞衰老。另有报道称,层蛋白A基因(lamin A,LMNA)第11外显子的从头突变导致层蛋白A(lamin A,LMNA)前信使核糖核酸的异常剪接导致HGPS患者细胞过早衰老和加速衰老。有趣的是,HGPS中层蛋白A的异常剪接产物(称为孕激素)随着年龄的变化在健康人的细胞和组织中积累,这表明mRNA剪接的变化不一定与突变有关,也可能受到年龄相关因素的影响。与这一思路一致的是,其他一些基因,包括细胞黏附分子纤维连接蛋白和中间丝蛋白波形蛋白,在正常衰老细胞中被交替剪接。这一想法也在与衰老相关的神经退行性疾病中得到了例证,如阿尔茨海默氏症、帕金森氏病和tauopathy,所有这些疾病都涉及前mRNAs剪接中的异常。基于上述发现,我们假设在细胞衰老过程中存在选择性剪接的广泛变化。其中一些与衰老相关的亚型可能是衰老细胞所特有的,对细胞建立衰老状态具有重要的功能,可以进一步开发成为新的衰老生物标志物。为了解决这一假设,我们将进行一系列调查,包括确定 使用RNA-seq(Aim1)剪接培养的衰老细胞的变化,在体外和体内表征这些与衰老相关的亚型,以将它们发展为衰老生物标记物(AIM2)。
英文摘要
DESCRIPTION (provided by applicant): Cellular aging is a powerful in vitro model for exploring molecular mechanisms underlying organismal aging. A popular hypothesis is that, when the telomeres shorten to below a critical point, it acts as a mitotic clock dictating the permanent exit from the cell cycle. Besides telomere shortening, cellular senescence can be triggered prematurely by certain oncogenes or environmental stimuli, such as γ-irradiation. It has also been reported that an aberrant splicing of the pre-mRNA of the lamin A gene (LMNA), due to a de novo mutation in the exon 11, leads to premature cellular senescence and accelerated aging in patients with Hutchinson-Gilford progeria syndrome (HGPS). Interestingly, a small amount of the aberrant splicing product of lamin A in HGPS (named "progerin") accumulates in the cells and tissues of healthy individuals as a function of age, suggesting that alterations in mRNA splicing are not necessarily associated with mutations and may also be influenced by age-related factors. Consistent with this line of thinking, a few other genes, including a cell adhesion molecule fibronectin and an intermediate filament protein vimentin, are alternatively spliced in normal senescent cells. This idea is also exemplified in aging-related neurodegenerative diseases, such as Alzheimer's, Parkinson's diseases and tauopathies, all involving aberrations in pre-mRNAs splicing. Based on the above findings, we hypothesize that there are widespread changes in alternative splicing during cellular senescence. Some of these senescence-related isoforms may be unique to senescent cells and functionally important for cells to establishing senescence state, which can be further developed into novel biomarkers for aging. To address this hypothesis, we will conduct a series of investigations including identifying splicing changes in cultured senescent cells using RNA-seq (Aim1), characterizing these senescence-associated isoforms in vitro and in vivo to develop them into aging biomarkers (Aim2).
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Comparing lamin proteins post-translational relative stability using a 2A peptide-based system reveals elevated resistance of progerin to cellular degradation.
使用基于 2A 肽的系统比较核纤层蛋白翻译后的相对稳定性,揭示了早老素对细胞降解的抵抗力增强。
DOI: 10.1080/19491034.2016.1260803
发表时间: 2016
期刊: Nucleus (Austin, Tex.)
影响因子: --
作者: [Wu,Di, Yates,PhillipA, Zhang,Haoyue, Cao,Kan]
通讯作者: Cao,Kan
Transient induction of telomerase expression mediates senescence and reduces tumorigenesis in primary fibroblasts.
端粒酶表达的瞬时诱导介导衰老并减少原代成纤维细胞的肿瘤发生。
DOI: 10.1073/pnas.1907199116
发表时间: 2019
期刊: Proceedings of the National Academy of Sciences of the United States of America
影响因子: 11.1
作者: [Sun,Linlin, Chiang,JeffreyY, Choi,JiYoung, Xiong,Zheng-Mei, Mao,Xiaojing, Collins,FrancisS, Hodes,RichardJ, Cao,Kan]
通讯作者: Cao,Kan
DOI: 10.1038/s41598-017-02419-3
发表时间: 2017-05-30
期刊: Scientific reports
影响因子: 4.6
作者: [Xiong ZM, O'Donovan M, Sun L, Choi JY, Ren M, Cao K]
通讯作者: Cao K
DOI: 10.1111/acel.12434
发表时间: 2016-04
期刊: Aging cell
影响因子: 7.8
作者: [Xiong ZM, Choi JY, Wang K, Zhang H, Tariq Z, Wu D, Ko E, LaDana C, Sesaki H, Cao K]
通讯作者: Cao K
Investigation of smooth muscle cell loss in progeria
  • 批准号:
    9486185
  • 项目类别:
  • 资助金额:
    $2.08万
  • 财政年份:
    2015
  • 负责人:
    KAN CAO
  • 依托单位:
Investigation of smooth muscle cell loss in progeria
  • 批准号:
    9026244
  • 项目类别:
  • 资助金额:
    $38.0万
  • 财政年份:
    2015
  • 负责人:
    KAN CAO
  • 依托单位:
Investigation of smooth muscle cell loss in progeria
  • 批准号:
    9195750
  • 项目类别:
  • 资助金额:
    $38.0万
  • 财政年份:
    2015
  • 负责人:
    KAN CAO
  • 依托单位:
Identification of Splicing-Related Aging Biomarkers
  • 批准号:
    8821400
  • 项目类别:
  • 资助金额:
    $22.2万
  • 财政年份:
    2014
  • 负责人:
    KAN CAO
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: